MoonLake Immunotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MLTX and other ETFs, options, and stocks.About MLTX
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
MLTX Key Statistics
Stock Snapshot
The current MoonLake Immunotherapeutics(MLTX) stock price is $17.75, with a market capitalization of 1.28B. The stock trades at a price-to-earnings (P/E) ratio of -5.11.
On 2026-03-06, MoonLake Immunotherapeutics(MLTX) stock traded between a low of $17.70 and a high of $18.33. Shares are currently priced at $17.75, which is +0.3% above the low and -3.2% below the high.
The MoonLake Immunotherapeutics(MLTX)'s current trading volume is 762.39K, compared to an average daily volume of 1.31M.
During the past year, MoonLake Immunotherapeutics(MLTX) stock moved between $5.95 at its lowest and $62.75 at its peak.
During the past year, MoonLake Immunotherapeutics(MLTX) stock moved between $5.95 at its lowest and $62.75 at its peak.
Analyst ratings
71%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.